Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Energy Biosystem Corp NASDAQ-ENBC -- Ignore unavailable to you. Want to Upgrade?

To: JSI who wrote (178)	10/7/1998 12:09:00 AM
From: Sector Investor	Read Replies (1) \| Respond to of 336

Energy Biosystems Announces Two Patents Issue and Talks Progress With Chemical Companies PR Newswire - October 06, 1998 09:21 THE WOODLANDS, Texas, Oct. 6 /PRNewswire/ -- Energy BioSystems (Nasdaq: ENBC) has been issued two new patents which strengthen the company's exclusive position on its BDS technology and expands its patent estate. The first patent "Rhodococcus Flavin Reductase Complementing DszA and DszC Activity", issued on September 8, 1998 as U.S. Patent No. 5,804,433. This invention provides a novel enzyme that activates an integral portion of the biodesulfurization pathway and increases the desulfurization rate. The second patent "DszD Utilization in Desulfurization of DBT by Rhodococcus sp. IGTS8", issued on September 22, 1998 as U.S Patent No. 5,811,285. This invention further describes the enhancement of desulfurization with the addition of complementary enzymes to the biocatalyst system. With these patents, Energy BioSystems currently has rights to 26 U.S. patents, 29 foreign patents, with 15 patent applications pending in the U.S. Patent Office and 80 foreign patent applications pending worldwide to cover its biocatalytic process technologies and biocatalyst genes. Energy BioSystems continues to progress in its development of biocatalytic desulfurization. In addition, we are encouraged by the strong interest from the major chemical companies that we have introduced to our novel and unusual chemical products from our biocatalytic reaction processes. The leading area of interest is in their potential to deliver unusual surfactant properties not normally observed with existing commercial surfactants. Energy BioSystems Corporation is a United States based leading edge biotechnology company developing biocatalytic processes for commercial petroleum refining and industrial production. The company has developed special knowledge in working with Rhodococcus and related bacterial genera and applied this knowledge to biocatalysis. Expertise in oxygenase biochemistry, particularly related to complex cellular pathways; and expertise in multi- phase systems add to our capabilities. The company's principle focus has been on developing biocatalytic desulfurization, a proprietary process using enzymes to remove sulfur from petroleum, including fuels, while operating at mild temperature and pressure. This process is expected to help refiners and vehicle manufacturers worldwide meet increasingly stringent environmental regulations in a more cost effective manner. Additional information about Energy BioSystems is available at the company's web site: www.energybiosystems.com. This document contains forward-looking statements that are subject to certain risks, uncertainties and assumptions. Should one or more of such risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated in such forward-looking statements. For a discussion of such risks and assumptions, see "Risk Factors" included in the Company's annual report or Form 10-K for the year ended December 31, 1997. SOURCE Energy BioSystems Corporation /CONTACT: Paul G. Brown III, Vice President, Finance & Administration of Energy BioSystems Corporation, 281-364-6140/ /Web site: energybiosystems.com